ArticleDiabetic medicine : a journal of the British Diabetic Association2026
It's a game changer in terms of diabetic management': A qualitative study of adolescents' and parents' experiences of a 6-month trial of continuous glucose monitoring in type 2 diabetes.
Article in Diabetic medicine : a journal of the British Diabetic Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo qualitatively explore adolescents with type 2 diabetes (T2D) using any treatment regimen and parents of such adolescents' experiences of a 6-month trial of continuous glucose monitoring (CGM) and its perceived barriers and facilitators.
methodsAdolescents provided with CGM sensors (Freestyle Libre 2) free of charge for 6 months and parents recruited from the outpatient paediatric diabetes clinic at the Women's and Children's Hospital, South Australia participated. Four adolescents and six parents participated in a separate focus group or a semi-structured interview within 1 month (baseline) of CGM use; three adolescents and four parents participated in a focus group after 6 months of CGM use. Data were analysed using reflexive thematic analysis.
resultsWe generated four themes: (1) A Convenient and Practical Tool for Adolescent Monitoring, Self-Management, Education, and Behaviour Change; (2) Enhanced Parental Diabetes Oversight and Reduced Family Emotional Burden; (3) Psychosocial, Practical, and Affordability Barriers to Adolescent CGM Use; (4) Education, Improved Adhesion, and Supportive School Environments as Facilitators of Adolescent CGM Use.
conclusionsAdolescents with T2D and parents perceived CGM as a more acceptable and convenient tool than finger prick blood glucose monitoring. CGM benefits included facilitating education, improving self-management skills, and promoting behavioural modification. CGM was also perceived to reduce families' emotional burden associated with diabetes management. Device limitations, including technology accuracy, alarms, and adhesion issues, posed challenges for families. Equitable access and funding models were the main barriers to the wider adoption of CGM in this population within Australia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.